Mark Christopher Capone - Net Worth and Insider Trading
Mark Christopher Capone Net Worth
The estimated net worth of Mark Christopher Capone is at least $3 Million dollars as of 2025-04-28. Mark Christopher Capone is the President & C.E.O. of Myriad Genetics Inc and owns about 440,833 shares of Myriad Genetics Inc (MYGN) stock worth over $3 Million. Details can be seen in Mark Christopher Capone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Christopher Capone has not made any transactions after 2019-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Christopher Capone
Mark Christopher Capone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Christopher Capone owns 2 companies in total, including Myriad Genetics Inc (MYGN) , and DermTech Inc (DMTKQ) .
Click here to see the complete history of Mark Christopher Capone’s form 4 insider trades.
Insider Ownership Summary of Mark Christopher Capone
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MYGN | Myriad Genetics Inc | 2019-08-01 | President & C.E.O. |
| DMTKQ | DermTech Inc | 2022-07-18 | director |
Mark Christopher Capone Latest Holdings Summary
Mark Christopher Capone currently owns a total of 1 stock. Mark Christopher Capone owns 440,833 shares of Myriad Genetics Inc (MYGN) as of August 1, 2019, with a value of $3 Million.
Latest Holdings of Mark Christopher Capone
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYGN | Myriad Genetics Inc | 2019-08-01 | 440,833 | 7.42 | 3,270,981 |
Holding Weightings of Mark Christopher Capone
Mark Christopher Capone Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Christopher Capone has made a total of 0 transactions in Myriad Genetics Inc (MYGN) over the past 5 years. The most-recent trade in Myriad Genetics Inc is the sale of 137,000 shares on August 1, 2019, which brought Mark Christopher Capone around $6 Million.
Insider Trading History of Mark Christopher Capone
- 1
Mark Christopher Capone Trading Performance
GuruFocus tracks the stock performance after each of Mark Christopher Capone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Christopher Capone is -21.02%. GuruFocus also compares Mark Christopher Capone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Christopher Capone within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Christopher Capone's insider trading performs compared to the benchmark.
Performance of Mark Christopher Capone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.88 | | | | | |
| Relative Return to S&P 500(%) | 0.17 | | | | | |
Mark Christopher Capone Ownership Network
Ownership Network List of Mark Christopher Capone
Ownership Network Relation of Mark Christopher Capone
Mark Christopher Capone Owned Company Details
What does Myriad Genetics Inc do?
Who are the key executives at Myriad Genetics Inc?
Mark Christopher Capone is the President & C.E.O. of Myriad Genetics Inc. Other key executives at Myriad Genetics Inc include director & President and CEO Paul J Diaz , Chief Scientific Officer Dale Muzzey , and SVP & Chief of Staff Margaret Ancona .
Myriad Genetics Inc (MYGN) Insider Trades Summary
Over the past 18 months, Mark Christopher Capone made no insider transaction in Myriad Genetics Inc (MYGN). Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 257,844 shares made by Paul J Diaz , a net sale of 60,000 shares made by Richard Bryan Riggsbee , and a net sale of 46,012 shares made by Reitan Colleen F .
In summary, during the past 3 months, insiders sold 0 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 408,770 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 408,770 shares.
Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myriad Genetics Inc Insider Transactions
Mark Christopher Capone Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Christopher Capone. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Christopher Capone's mailing address is: Salt Lake City Ut 84108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
